Radiation Recall Dermatitis after the Use of Pralatrexate for Peripheral T-cell Lymphoma

Radiation recall dermatitis (RRD) is a well-known but poorly understood phenomenon. This clinical entity is uncommon with an estimated incidence of 1% to 10% in patients who receive systemic agents after radiation therapy (RT).